PubRank

William M Ridgway

Author PubWeight™ 42.05‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Liver autoimmunity triggered by microbial activation of natural killer T cells. Cell Host Microbe 2008 2.30
2 Anti-mitochondrial antibodies and primary biliary cirrhosis in TGF-beta receptor II dominant-negative mice. J Immunol 2006 2.18
3 NOD.c3c4 congenic mice develop autoimmune biliary disease that serologically and pathogenetically models human primary biliary cirrhosis. J Exp Med 2006 2.16
4 Loss of tolerance in C57BL/6 mice to the autoantigen E2 subunit of pyruvate dehydrogenase by a xenobiotic with ensuing biliary ductular disease. Hepatology 2008 2.05
5 Deletion of interleukin (IL)-12p35 induces liver fibrosis in dominant-negative TGFβ receptor type II mice. Hepatology 2013 1.78
6 Adoptive transfer of CD8(+) T cells from transforming growth factor beta receptor type II (dominant negative form) induces autoimmune cholangitis in mice. Hepatology 2008 1.45
7 Natural killer T cells exacerbate liver injury in a transforming growth factor beta receptor II dominant-negative mouse model of primary biliary cirrhosis. Hepatology 2008 1.30
8 Genetic control of autoimmunity: protection from diabetes, but spontaneous autoimmune biliary disease in a nonobese diabetic congenic strain. J Immunol 2004 1.29
9 B cells suppress the inflammatory response in a mouse model of primary biliary cirrhosis. Gastroenterology 2008 1.17
10 Differential mechanisms in the pathogenesis of autoimmune cholangitis versus inflammatory bowel disease in interleukin-2Ralpha(-/-) mice. Hepatology 2009 1.11
11 New insights to the immunopathology and autoimmune responses in primary biliary cirrhosis. Cell Immunol 2006 1.11
12 NOD mice and autoimmunity. Autoimmun Rev 2005 1.09
13 Overexpression of microRNA-21 is associated with elevated pro-inflammatory cytokines in dominant-negative TGF-β receptor type II mouse. J Autoimmun 2013 1.08
14 Deletion of interleukin-6 in mice with the dominant negative form of transforming growth factor beta receptor II improves colitis but exacerbates autoimmune cholangitis. Hepatology 2010 1.01
15 Modulating protective and pathogenic CD4+ subsets via CD137 in type 1 diabetes. Diabetes 2007 1.00
16 Species-specific immune responses generated by histidyl-tRNA synthetase immunization are associated with muscle and lung inflammation. J Autoimmun 2007 0.99
17 Clonality, activated antigen-specific CD8(+) T cells, and development of autoimmune cholangitis in dnTGFβRII mice. Hepatology 2013 0.98
18 The immunobiology of colitis and cholangitis in interleukin-23p19 and interleukin-17A deleted dominant negative form of transforming growth factor beta receptor type II mice. Hepatology 2012 0.98
19 Increased nonobese diabetic Th1:Th2 (IFN-gamma:IL-4) ratio is CD4+ T cell intrinsic and independent of APC genetic background. J Immunol 2002 0.98
20 CD8 T cells mediate direct biliary ductule damage in nonobese diabetic autoimmune biliary disease. J Immunol 2010 0.93
21 Animal models of primary biliary cirrhosis. Clin Liver Dis 2008 0.92
22 The B10 Idd9.3 locus mediates accumulation of functionally superior CD137(+) regulatory T cells in the nonobese diabetic type 1 diabetes model. J Immunol 2012 0.92
23 Genome-wide microarray expression analysis of CD4+ T Cells from nonobese diabetic congenic mice identifies Cd55 (Daf1) and Acadl as candidate genes for type 1 diabetes. J Immunol 2008 0.91
24 Identification of Cd101 as a susceptibility gene for Novosphingobium aromaticivorans-induced liver autoimmunity. J Immunol 2011 0.90
25 Murine models of autoimmune cholangitis. Curr Opin Gastroenterol 2010 0.88
26 Evidence that Cd101 is an autoimmune diabetes gene in nonobese diabetic mice. J Immunol 2011 0.88
27 Autoimmune cholangitis in NOD.c3c4 mice is associated with cholangiocyte-specific Fas antigen deficiency. J Autoimmun 2007 0.88
28 Animal models of primary biliary cirrhosis: materials and methods. Methods Mol Biol 2012 0.86
29 B cells promote hepatic inflammation, biliary cyst formation, and salivary gland inflammation in the NOD.c3c4 model of autoimmune cholangitis. Cell Immunol 2011 0.86
30 Genetic control of anti-Sm autoantibody production in NOD congenic mice narrowed to the Idd9.3 region. Immunogenetics 2006 0.85
31 The non-obese diabetic (NOD) mouse as a model of human type 1 diabetes. Methods Mol Biol 2012 0.85
32 Murine models of primary biliary cirrhosis: Comparisons and contrasts. Hepatol Res 2007 0.84
33 Nonobese diabetic CD4 lymphocytosis maps outside the MHC locus on chromosome 17. Immunogenetics 2004 0.81
34 Characterization of TLR4-mediated auto-antibody production in a mouse model of histidyl-tRNA synthetase-induced myositis. Innate Immun 2012 0.81
35 Recombinant soluble CD137 prevents type one diabetes in nonobese diabetic mice. J Autoimmun 2013 0.81
36 Lymphoma-like T cell infiltration in liver is associated with increased copy number of dominant negative form of TGFβ receptor II. PLoS One 2012 0.79
37 Reply: To PMID 22996325. Hepatology 2013 0.75
38 Functional redundancy of MyD88-dependent signaling pathways in a murine model of histidyl-transfer RNA synthetase-induced myositis. J Immunol 2013 0.75
39 Targeting innate immunity for treatment of type 1 diabetes. Immunotherapy 2014 0.75
40 A modular theory of autoimmunity. Keio J Med 2005 0.75